The role of hormonal therapy in prostate brachytherapy. Point.
Stock
Richard G
RG
Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY, USA.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism / Q000528:radiation effects; D001918:Brachytherapy; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects; D011471:Prostatic Neoplasms / Q000628:therapy*; D020266:Radiotherapy, Conformal; D018570:Risk Assessment
D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen